Skip to main content

Table 4 Genotype and allele distributions between responders and non-responders of PPARD rs2016520 and NOS1AP rs12742393 variants (n = 60)

From: PPARD rs2016520 (T/C) and NOS1AP rs12742393 (A/C) polymorphisms affect therapeutic efficacy of nateglinide in Chinese patients with type 2 diabetes mellitus

PPARD rs2016520

Genotype

P value

Allele frequency

P value

TT

TC

CC

T

C

Responder (%)

19 (54.29%)

11 (47.83%)

1 (50.00%)

 

49 (52.69%)

13 (48.15%)

 

Non-responder (%)

16 (45.71%)

12 (52.17%)

1 (50.00%)

0.964

44 (47.31%)

14 (51.85%)

0.678

NOS1AP rs12742393

AA

AC

CC

 

A

C

 

Responder (%)

17 (70.83%)

12 (44.44%)

2 (22.22%)

 

46 (61.33%)

16 (35.56%)

 

Non-responder (%)

7 (29.17%)

1 5 (55.56%)

7 (77.78%)

0.027

29 (38.67%)

29 (64.44%)

0.006